Indian Journal of Medical and Paediatric Oncology

ORIGINAL ARTICLE
Year
: 2013  |  Volume : 34  |  Issue : 3  |  Page : 211--212

Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology


KG Srinivas, Shekar Patil, Shashidhara 
 Department of Medical Oncology, Health-Care Global, Bangalore Institute of Oncology, Bengaluru, Karnataka, India

Correspondence Address:
K G Srinivas
Department of Medical Oncology, Health-Care Global, Bangalore Institute of Oncology, Bengaluru, Karnataka
India

Health-Care Global, Bangalore Institute of Oncology is a cancer care center, which provides comprehensive care for cancer patients. Here, we present data of 350 patients diagnosed as cases of chronic myeloid leukemia over a period of 10 years. In our patient population, there was male predominance and majority of patients lied between the age group of 40 and 50 years. 90% patients were initially started on 400 mg dose of imatinib. About 30% of patient population required dose excalation due to inadequate response while 10% required dose descalation due to myelosuppression. 60% of patients had complete response by 3 months and 52% of patients had major molecular response by 1 year.


How to cite this article:
Srinivas K G, Patil S, Shashidhara. Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology.Indian J Med Paediatr Oncol 2013;34:211-212


How to cite this URL:
Srinivas K G, Patil S, Shashidhara. Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology. Indian J Med Paediatr Oncol [serial online] 2013 [cited 2019 Aug 24 ];34:211-212
Available from: http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=211;epage=212;aulast=Srinivas;type=0